Nautilus Biotechnolgy Inc. (NASDAQ: NAUT)
$2.4450
+0.0650 ( +1.88% ) 32.3K
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
Market Data
Open
$2.4450
Previous close
$2.3800
Volume
32.3K
Market cap
$303.87M
Day range
$2.3550 - $2.4500
52 week range
$2.1900 - $3.4547
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| ars | Annual reports | 1 | Apr 26, 2024 |
| 4 | Insider transactions | 1 | Mar 11, 2024 |
| 4 | Insider transactions | 1 | Mar 07, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |